Acute high-dose methotrexate neurotoxicity in the rat

Area of Science:

• Neuroscience
• Oncology
• Pharmacology

Background:

• High-dose methotrexate chemotherapy is associated with neurotoxicity.
• Acute encephalopathies are increasingly recognized following this treatment.
• Understanding the mechanisms of methotrexate neurotoxicity is crucial for patient safety.

Purpose of the Study:

• To establish a reliable animal model for acute high-dose methotrexate neurotoxicity.
• To investigate the biochemical and physiological changes associated with this neurotoxicity.
• To provide a platform for evaluating potential therapeutic interventions.

Main Methods:

• Developed an acute high-dose methotrexate neurotoxicity model in rats.
• Assessed cerebral glucose metabolism using quantitative methods.
• Monitored behavioral and electroencephalographic (EEG) abnormalities.
• Analyzed amino acid profiles in brain tissue.

Main Results:

• The rat model demonstrated a profound, dose-dependent depression of cerebral glucose metabolism.
• Significant behavioral and electroencephalographic abnormalities were observed.
• Amino acid profile alterations were detected, mirroring those in human patients.
• No biochemical evidence of systemic organ toxicity was found.

Conclusions:

• The developed rat model accurately reflects acute high-dose methotrexate neurotoxicity.
• This model allows for the study of antifolate neurotoxicity mechanisms.
• It serves as a valuable tool for testing therapeutic strategies against methotrexate-induced neurotoxicity.